MORRISVILLE, NC, January 24, 2017 – Worldwide Clinical Trials (www.worldwide.com) has been named “Best in Neuroscience Therapeutics” in the 2016 Corporate LiveWire Healthcare and Life Science Awards.
The Corporate LiveWire Healthcare and Life Science Awards recognize the pinnacle of business achievement and organizations that have made a difference in patient lives. It celebrates the most innovative and successful projects carried out around the world over the previous 12 months, selected by a judging panel that chooses the winners based on the most ground-breaking companies, teams and individuals who have transformed global healthcare.
“As Worldwide’s expertise in central nervous system clinical research is unrivalled, it’s great validation to have been named ‘Best in Neuroscience Therapeutics’ in the Corporate LiveWire Healthcare and Life Science Awards,” said Peter Benton, President and COO at Worldwide. “Our staff has contributed to the development of every drug class applicable to Alzheimer’s disease over the past 20 years, and this award recognizes our neuroscience team’s unwavering commitment and passion to helping find treatements for patients around the world who suffer from central nervous system disorders.”
For additional information about the award, visit the Corporate LiveWire website.
Connect with Worldwide Clinical Trials:
Corporate LiveWire Healthcare and Life Science Awards name @worldwidetrials as Best in Neuroscience Therapeutics
Follow us on Twitter: @worldwidetrials
Find us on LinkedIn: https://www.linkedin.com/company/worldwide-clinical-trials-inc-
About Worldwide Clinical Trials
Worldwide Clinical Trials employs more than 1,400 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. One of the world’s leading, full-service contract research organizations (CROs), we partner with sponsors in the pharmaceutical and biotechnology industries to deliver fully integrated clinical development and bioanalytical services, extending from first-in-human through phase IV studies. Grounded in medicine and science, we help sponsors move from medical discovery into clinical development and commercialization across a range of therapeutic areas, including neuroscience, cardiovascular diseases, immune-mediated inflammatory disorders (IMID), and rare diseases. For more information, visit www.worldwide.com.
